Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly alteplase lock versus trisodium citrate lock for tunneled dialysis catheter infection and obstruction prevention
ACTRN12612000152820Phase 4Recruiting
- Sponsor
- Pavlina Richtrova, MD, PhD
- Start
- Feb 2012
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tissue-plasminogen activator and trisodium citrate, sponsored by Pavlina Richtrova, MD, PhD. Started Feb 2012; status: recruiting.
02
Drugs
tissue-plasminogen activatortrisodium citrate
Beyond the preview
Go deeper on ACTRN12612000152820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000152820.